by 
The shigella test kit market involves products that are used to identify the presence of Shigella bacteria species that cause the intestinal infection shigellosis or bacillary dysentery. Shigella test kits help detect shigellosis through rapid immunochromatographic or enzyme immunoassay techniques which provide results within a short period. Mainly of two types – rapid test kits and ELISA test kits, these products are used at hospitals, diagnostic labs, clinics and other healthcare settings to effectively diagnose shigellosis. Rapid kits provide visual results within 15-30 minutes while ELISA kits involve laboratory procedures and take around 2-3 hours to process samples and provide accurate test results.
The global shigella test kit market is estimated to be valued at US$ 106.4 Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
The Shigella Test Kit Market is expected to be propelled by the increasing prevalence of shigellosis globally. As per the World Health Organization (WHO), every year shigellosis infects approximately 164.7 million people worldwide, especially affecting developing countries with poor sanitation conditions. The rising pollution levels and contaminated water supplies have further increased risks of shigellosis transmission. This has subsequently raised the demand for accurate and timely diagnosis of the disease through effective shigella test kits. Moreover, growing research and development activities by leading players for developing advanced shigella testing solutions will also aid the market growth over the forecast period. For instance, introduction of portable and battery-operated rapid diagnostic kits have enhanced point-of-care testing capability in resource-limited areas.
Segment Analysis
The global Shigella Test Kit Market is dominated by the ELISA sub segment. ELISA tests provide accurate and early diagnosis of Shigella infection and are faster and more convenient when compared to other tests like bacterial culture tests. The bacteria Shigella causes shigellosis which is an infectious disease mainly affecting children and immune-compromised adults. The ELISA test kits detect the presence of antibodies or antigens in stool samples which indicates Shigella infection and aids in prompt treatment.
PEST Analysis
Political: Healthcare expenditure and funding for infectious disease control is expected to increase in major markets which will drive growth. Social: Rising awareness about waterborne diseases and their diagnosis is promoting use of test kits. Economic: High disease burden and productivity losses due to shigellosis globally presents market opportunity. Technological: Developments in molecular diagnostic techniques promise enhanced accuracy and speed.
Key Takeaways
The global Shigella Test Kit Market is expected to witness high growth during the forecast period of 2023 to 2030.
Regional analysis shows North America dominates currently due rapid diagnosis adoption. Asia Pacific is poised to emerge as the fastest growing regional market driven by growing disease awareness and healthcare infrastructure development.
Key players operating in the Shigella Test Kit market include Thermo Fisher Scientific Inc., Meridian Bioscience Inc., QIAGEN N.V., Bio-Rad Laboratories Inc., Creative Diagnostics, Hardy Diagnostics, Luminex Corporation, DiaSorin S.p.A., Sekisui Diagnostics LLC, BioMérieux SA, MP Biomedicals LLC, Coris BioConcept, Alere Inc., Fujirebio Diagnostics Inc., and CTK Biotech Inc. Thermo Fisher Scientific Inc and QIAGEN N.V have strong geographic presence and product portfolios delivering high accuracy test results
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
